Geode Capital Management, LLC Petros Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.47 - $5.1 $604 - $6,563	1,287 Added 1.71%	76,654 $39,000
Q2 2022 Aug 12, 2022	BUY	$0.68 - $1.49 $3,703 - $8,116	5,447 Added 7.79%	75,367 $61,000
Q1 2022 May 13, 2022	BUY	$1.07 - $3.36 $11,914 - $37,413	11,135 Added 18.94%	69,920 $109,000
Q4 2021 Feb 11, 2022	BUY	$1.33 - $4.09 $46,629 - $143,395	35,060 Added 147.78%	58,785 $195,000
Q2 2021 Aug 13, 2021	BUY	$2.87 - $4.11 $27,394 - $39,229	9,545 Added 67.31%	23,725 $74,000
Q1 2021 May 12, 2021	BUY	$2.85 - $4.6 $40,413 - $65,227	14,180 New	14,180 $52,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $5.18M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.